ClinConnect ClinConnect Logo
Search / Trial NCT05546593

Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 15, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Gout Ultrasound Microcrystal Disease

ClinConnect Summary

This clinical trial is studying how common certain changes are in the joints and tendons of patients with gout, a type of arthritis that often affects men over the age of 40. Gout occurs when there are deposits of a substance called sodium urate in the body, which can cause pain and swelling. The researchers want to use ultrasound, a safe imaging technique, to look for signs of inflammation, structural damage, and the presence of these deposits in the joints and tendons of gout patients. This study will help understand how gout affects the body and can guide better treatment options.

To participate in this trial, individuals must be adults diagnosed with gout based on specific medical guidelines, and they should be able to provide informed consent. The study is open to people from 65 years and older, and it is important that they do not have other chronic inflammatory diseases. Participants will undergo ultrasound examinations to assess the state of their joints and tendons. This research will provide valuable insights into gout and how it impacts patients, which can help improve care for those living with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion criteria were adult patients with a diagnosis of gout according to ACR/EULAR 2015 criteria and able to give informed consent. Exclusion criteria were the presence of other chronic inflammatory rheumatic diseases and patients without French social insurance.
  • Exclusion Criteria:
  • -

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Boulogne Billancourt, Aphp, France

Patients applied

0 patients applied

Trial Officials

Maria-Antonietta D'AGOSTINO, MD, PhD

Principal Investigator

Rhumatology department, Ambroise Paré hospital - APHP

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials